These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 35078345

  • 21. Differentiated thyroid carcinomas with vascular invasion: a comparative study of follicular, Hürthle cell and papillary thyroid carcinoma.
    Mai KT, Khanna P, Yazdi HM, Perkins DG, Veinot JP, Thomas J, Lamba M, Nair BD.
    Pathology; 2002 Jun; 34(3):239-44. PubMed ID: 12109784
    [Abstract] [Full Text] [Related]

  • 22. Role of the Degree of Vascular Invasion in Predicting Prognosis of Follicular Thyroid Carcinoma.
    Yamazaki H, Sugino K, Katoh R, Matsuzu K, Kitagawa W, Nagahama M, Rino Y, Saito A, Ito K.
    J Clin Endocrinol Metab; 2024 Apr 19; 109(5):1291-1300. PubMed ID: 38006314
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Expression of epithelial-mesenchymal transition regulators TWIST, SLUG and SNAIL in follicular thyroid tumours may relate to widely invasive, poorly differentiated and distant metastasis.
    Wu J, Zhang Y, Cheng R, Gong W, Ding T, Zhai Q, Wang Y, Meng B, Sun B.
    Histopathology; 2019 Apr 19; 74(5):780-791. PubMed ID: 30368884
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Clinicopathological Characteristics and Disease-Free Survival in Patients with Hürthle Cell Carcinoma: A Multicenter Cohort Study in South Korea.
    Jin M, Kim ES, Kim BH, Kim HK, Kang YE, Jeon MJ, Kim TY, Kang HC, Kim WB, Shong YK, Kim M, Kim WG.
    Endocrinol Metab (Seoul); 2021 Oct 19; 36(5):1078-1085. PubMed ID: 34731935
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
    van Velsen EFS, Stegenga MT, van Kemenade FJ, Kam BLR, van Ginhoven TM, Visser WE, Peeters RP.
    Thyroid; 2018 Aug 19; 28(8):976-981. PubMed ID: 29848239
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Significance of oncocytic features in poorly differentiated thyroid carcinoma - a bi-institutional experience.
    Xu B, Lubin DJ, Dogan S, Ghossein RA, Viswanathan K.
    Virchows Arch; 2023 Mar 19; 482(3):479-491. PubMed ID: 36346459
    [Abstract] [Full Text] [Related]

  • 33. Minimally invasive follicular thyroid cancer: treat as a benign or malignant lesion?
    Robinson A, Schneider D, Sippel R, Chen H.
    J Surg Res; 2017 Jan 19; 207():235-240. PubMed ID: 27979483
    [Abstract] [Full Text] [Related]

  • 34. Prognostic Significance of Extent of Invasion in Poorly Differentiated Thyroid Carcinoma.
    Wong KS, Lorch JH, Alexander EK, Marqusee E, Cho NL, Nehs MA, Doherty GM, Barletta JA.
    Thyroid; 2019 Sep 19; 29(9):1255-1261. PubMed ID: 31397224
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Prognostic factors for follicular thyroid carcinoma: the importance of vascular invasion.
    Ito Y, Hirokawa M, Masuoka H, Higashiyama T, Kihara M, Onoda N, Miya A, Miyauchi A.
    Endocr J; 2022 Sep 28; 69(9):1149-1156. PubMed ID: 35491160
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Prognostic value of vascular invasion in well-differentiated papillary thyroid carcinoma.
    Wreesmann VB, Nixon IJ, Rivera M, Katabi N, Palmer F, Ganly I, Shaha AR, Tuttle RM, Shah JP, Patel SG, Ghossein RA.
    Thyroid; 2015 May 28; 25(5):503-8. PubMed ID: 25748079
    [Abstract] [Full Text] [Related]

  • 39. Minimally invasive follicular thyroid carcinomas: prognostic factors.
    Stenson G, Nilsson IL, Mu N, Larsson C, Lundgren CI, Juhlin CC, Höög A, Zedenius J.
    Endocrine; 2016 Aug 28; 53(2):505-11. PubMed ID: 26858184
    [Abstract] [Full Text] [Related]

  • 40. Pathologic study and clinical significance of Hürthle cell papillary thyroid carcinoma.
    Mai KT, Thomas J, Yazdi HM, Commons AS, Lamba M, Stinson AW.
    Appl Immunohistochem Mol Morphol; 2004 Dec 28; 12(4):329-37. PubMed ID: 15536332
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.